State of New Jersey Common Pension Fund D’s Vaxcyte PCVX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.34M	Buy	40,264 +384	+1%	+$20.8K	0.01%	939
2025 Q4	$1.84M	Sell	39,880 -26,778	-40%	-$1.2M	0.01%	1354
2025 Q3	$2.4M	Buy	66,658 +11,181	+20%	+$370K	0.01%	925
2025 Q2	$1.8M	Buy	55,477 +14,799	+36%	+$485K	0.01%	1364
2025 Q1	$1.54M	Sell	40,678 -4,223	-9%	-$338K	0.01%	1413
2024 Q4	$3.68M	Buy	44,901 +5,427	+14%	+$539K	0.01%	684
2024 Q3	$4.51M	Hold	39,474	–	–	0.02%	612
2024 Q2	$2.98M	Sell	39,474 -13,955	-26%	-$950K	0.01%	734
2024 Q1	$3.65M	Buy	53,429 +5,048	+10%	+$350K	0.01%	864
2023 Q4	$3.04M	Hold	48,381	–	–	0.01%	1001
2023 Q3	$2.47M	Hold	48,381	–	–	0.01%	1063
2023 Q2	$2.42M	Sell	48,381 -4,342	-8%	-$206K	0.01%	1409
2023 Q1	$1.98M	Hold	52,723	–	–	0.01%	1497
2022 Q4	$2.53M	Buy	+52,723	New	+$2.07M	0.01%	988

Other funds holding PCVX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of New Jersey Common Pension Fund D's PCVX Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D increased its Vaxcyte (PCVX) stake by 0.96% in Q1 2026, buying an estimated $20.8K and bringing the position to 40,264 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #939.

State of New Jersey Common Pension Fund D first reported a position in PCVX in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.51M in Q3 2024. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

State of New Jersey Common Pension Fund D held 40,264 shares of Vaxcyte worth $2.34M as of Q1 2026.
State of New Jersey Common Pension Fund D bought 384 Vaxcyte shares in Q1 2026, an estimated $20.8K.
Vaxcyte made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #939 holding.
State of New Jersey Common Pension Fund D first reported a position in Vaxcyte in Q4 2022 and has held it in 14 quarters since.
State of New Jersey Common Pension Fund D's Vaxcyte position peaked at $4.51M in Q3 2024.
336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.